Biocon Balance Sheet Health
Financial Health criteria checks 1/6
Biocon has a total shareholder equity of ₹242.8B and total debt of ₹182.5B, which brings its debt-to-equity ratio to 75.2%. Its total assets and total liabilities are ₹545.8B and ₹303.0B respectively. Biocon's EBIT is ₹20.2B making its interest coverage ratio 2.3. It has cash and short-term investments of ₹37.9B.
Key information
75.2%
Debt to equity ratio
₹182.52b
Debt
Interest coverage ratio | 2.3x |
Cash | ₹37.86b |
Equity | ₹242.77b |
Total liabilities | ₹303.00b |
Total assets | ₹545.77b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532523's short term assets (₹140.7B) exceed its short term liabilities (₹103.7B).
Long Term Liabilities: 532523's short term assets (₹140.7B) do not cover its long term liabilities (₹199.3B).
Debt to Equity History and Analysis
Debt Level: 532523's net debt to equity ratio (59.6%) is considered high.
Reducing Debt: 532523's debt to equity ratio has increased from 34.2% to 75.2% over the past 5 years.
Debt Coverage: 532523's debt is not well covered by operating cash flow (6.4%).
Interest Coverage: 532523's interest payments on its debt are not well covered by EBIT (2.3x coverage).